P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Operating Margin
PharmaResearch Co Ltd

34.5%
Current
34%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
34.5%
=
Operating Profit
102.2B
/
Revenue
296.6B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
PharmaResearch Co Ltd
KOSDAQ:214450
2T KRW
34%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
312.7B USD
28%
US
Amgen Inc
NASDAQ:AMGN
158.3B USD
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD
40%
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
133.6B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.8B EUR
-22%
Country KR
Market Cap 2T KRW
Operating Margin
34%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 312.7B USD
Operating Margin
28%
Country US
Market Cap 158.3B USD
Operating Margin
19%
Country US
Market Cap 116.2B USD
Operating Margin
40%
Country US
Market Cap 112.4B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 133.6B AUD
Operating Margin
26%
Country US
Market Cap 81.3B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.8B EUR
Operating Margin
-22%
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
34.5%
=
Operating Profit
102.2B
/
Revenue
296.6B
What is the Operating Margin of PharmaResearch Co Ltd?

Based on PharmaResearch Co Ltd's most recent financial statements, the company has Operating Margin of 34.5%.